Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-11

Clinical Trial Update: A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide [Phase 4]

View source ↗

Summary

A Phase 4 study used imaging to measure changes in bone structure after treatment with teriparatide in postmenopausal osteoporosis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Forteo (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED | Results posted: 2011-11-11